ASTERA LABS INC (ALAB)

US04626A1034 - Common Stock

132.17  +6.89 (+5.5%)

After market: 134 +1.83 (+1.38%)

Fundamental Rating

4

ALAB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. ALAB has a great financial health rating, but its profitability evaluates not so good. ALAB is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year ALAB has reported negative net income.

1.2 Ratios

ALAB has a worse Return On Assets (-2.67%) than 61.11% of its industry peers.
ALAB has a Return On Equity of -2.95%. This is in the lower half of the industry: ALAB underperforms 61.11% of its industry peers.
Industry RankSector Rank
ROA -2.67%
ROE -2.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 68.94%, ALAB belongs to the top of the industry, outperforming 92.59% of the companies in the same industry.
ALAB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

ALAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALAB remains at a similar level compared to 1 year ago.
There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 135.33 indicates that ALAB is not in any danger for bankruptcy at the moment.
ALAB has a better Altman-Z score (135.33) than 99.07% of its industry peers.
There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 135.33
ROIC/WACCN/A
WACC15.53%

2.3 Liquidity

A Current Ratio of 10.74 indicates that ALAB has no problem at all paying its short term obligations.
The Current ratio of ALAB (10.74) is better than 97.22% of its industry peers.
A Quick Ratio of 10.46 indicates that ALAB has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 10.46, ALAB belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.74
Quick Ratio 10.46

5

3. Growth

3.1 Past

ALAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.00%, which is quite impressive.
Looking at the last year, ALAB shows a very strong growth in Revenue. The Revenue has grown by 44.97%.
EPS 1Y (TTM)55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)44.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 77.08% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALAB will show a very strong growth in Revenue. The Revenue will grow by 63.36% on average per year.
EPS Next Y528.12%
EPS Next 2Y199.77%
EPS Next 3Y127.96%
EPS Next 5Y77.08%
Revenue Next Year235.07%
Revenue Next 2Y131.89%
Revenue Next 3Y92.41%
Revenue Next 5Y63.36%

3.3 Evolution

2

4. Valuation

4.1 Price/Earnings Ratio

ALAB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 109.88, which means the current valuation is very expensive for ALAB.
Based on the Price/Forward Earnings ratio, ALAB is valued a bit more expensive than 62.04% of the companies in the same industry.
ALAB is valuated expensively when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 109.88

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ALAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALAB's earnings are expected to grow with 127.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y199.77%
EPS Next 3Y127.96%

0

5. Dividend

5.1 Amount

ALAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASTERA LABS INC

NASDAQ:ALAB (12/20/2024, 8:00:00 PM)

After market: 134 +1.83 (+1.38%)

132.17

+6.89 (+5.5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners43.54%
Inst Owner Change37.32%
Ins Owners16.95%
Ins Owner Change-38.95%
Market Cap20.96B
Analysts84.44
Price Target103.36 (-21.8%)
Short Float %6.34%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.11%
Min EPS beat(2)15.86%
Max EPS beat(2)32.36%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)8.88%
Min Revenue beat(2)3.98%
Max Revenue beat(2)13.78%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)35.29%
PT rev (3m)45.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)111.24%
EPS NY rev (1m)6.14%
EPS NY rev (3m)28.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)48.56%
Revenue NY rev (1m)1.86%
Revenue NY rev (3m)10.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 109.88
P/S 181.04
P/FCF N/A
P/OCF N/A
P/B 23.56
P/tB 23.56
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)1.2
Fwd EY0.91%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.73
BVpS5.61
TBVpS5.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.67%
ROE -2.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.94%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.74
Quick Ratio 10.46
Altman-Z 135.33
F-ScoreN/A
WACC15.53%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y528.12%
EPS Next 2Y199.77%
EPS Next 3Y127.96%
EPS Next 5Y77.08%
Revenue 1Y (TTM)44.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year235.07%
Revenue Next 2Y131.89%
Revenue Next 3Y92.41%
Revenue Next 5Y63.36%
EBIT growth 1Y51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year301.95%
EBIT Next 3Y140.38%
EBIT Next 5Y87.89%
FCF growth 1Y61.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.58%
OCF growth 3YN/A
OCF growth 5YN/A